United States · FDA National Drug Code directory
Sofosbuvir and Velpatasvir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72626-2701_314b9ef7-c6e5-44c9-9fbf-b0d35a24cd7d
- Product NDC
- 72626-2701
- Form
- TABLET, FILM COATED
- Composition / generic term
- Velpatasvir and Sofosbuvir
- Labeler
- Asegua Therapeutics LLC
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20181114
- Source listing expiry
- 20261231
Source-listed ingredients
- VELPATASVIR — 100 mg/1
- SOFOSBUVIR — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BLISTER PACK in 1 CARTON (72626-2701-1) / 14 TABLET, FILM COATED in 1 BLISTER PACK · 72626-2701-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →